Botwood N - Search Results

1

Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer.

Blumenthal GM, Bunn PA Jr, Chaft JE, McCoach CE, Perez EA, Scagliotti GV, Carbone DP, Aerts HJWL, Aisner DL, Bergh J, Berry DA, Jarkowski A, Botwood N, Cross DAE, Diehn M, Drezner NL, Doebele RC, Blakely CM, Eberhardt WEE, Felip E, Gianni L, Keller SP, Leavey PJ, Malik S, Pignatti F, Prowell TM, Redman MW, Rizvi NA, Rosell R, Rusch V, de Ruysscher D, Schwartz LH, Sridhara R, Stahel RA, Swisher S, Taube JM, Travis WD, Keegan P, Wiens JR, Wistuba II, Wynes MW, Hirsch FR, Kris MG. Blumenthal GM, et al. Among authors: botwood n. J Thorac Oncol. 2018 Dec;13(12):1818-1831. doi: 10.1016/j.jtho.2018.09.017. Epub 2018 Sep 27. J Thorac Oncol. 2018. PMID: 30268698 Free article. Review.

2

Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.

Hirsch FR, Varella-Garcia M, Bunn PA Jr, Franklin WA, Dziadziuszko R, Thatcher N, Chang A, Parikh P, Pereira JR, Ciuleanu T, von Pawel J, Watkins C, Flannery A, Ellison G, Donald E, Knight L, Parums D, Botwood N, Holloway B. Hirsch FR, et al. Among authors: botwood n. J Clin Oncol. 2006 Nov 1;24(31):5034-42. doi: 10.1200/JCO.2006.06.3958. J Clin Oncol. 2006. PMID: 17075123 Clinical Trial.

3

Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study.

Chang A, Parikh P, Thongprasert S, Tan EH, Perng RP, Ganzon D, Yang CH, Tsao CJ, Watkins C, Botwood N, Thatcher N. Chang A, et al. Among authors: botwood n. J Thorac Oncol. 2006 Oct;1(8):847-55. J Thorac Oncol. 2006. PMID: 17409969 Free article. Clinical Trial.

4

Combination therapy with gefitinib and rofecoxib in patients with platinum-pretreated relapsed non small-cell lung cancer.

O'Byrne KJ, Danson S, Dunlop D, Botwood N, Taguchi F, Carbone D, Ranson M. O'Byrne KJ, et al. Among authors: botwood n. J Clin Oncol. 2007 Aug 1;25(22):3266-73. doi: 10.1200/JCO.2006.09.2791. J Clin Oncol. 2007. PMID: 17664473 Clinical Trial.

5

Phase III trial of FOLFOX plus bevacizumab or cediranib (AZD2171) as first-line treatment of patients with metastatic colorectal cancer: HORIZON III.

Robertson JD, Botwood NA, Rothenberg ML, Schmoll HJ. Robertson JD, et al. Among authors: botwood na. Clin Colorectal Cancer. 2009 Jan;8(1):59-60. doi: 10.3816/CCC.2009.n.010. Clin Colorectal Cancer. 2009. PMID: 19203899 Clinical Trial.

6

Gefitinib and irinotecan in patients with fluoropyrimidine-refractory, irinotecan-naive advanced colorectal cancer: a phase I-II study.

Chau I, Cunningham D, Hickish T, Massey A, Higgins L, Osborne R, Botwood N, Swaisland A. Chau I, et al. Among authors: botwood n. Ann Oncol. 2007 Apr;18(4):730-7. doi: 10.1093/annonc/mdl481. Epub 2007 Jan 20. Ann Oncol. 2007. PMID: 17237473 Free article. Clinical Trial.

7

Raltitrexed plus radiotherapy for the treatment of unresectable/recurrent rectal cancer: a phase I study.

James RD, Botwood N, Vernon CC, Price P. James RD, et al. Among authors: botwood n. Ann Oncol. 2003 Apr;14(4):570-3. doi: 10.1093/annonc/mdg165. Ann Oncol. 2003. PMID: 12649103 Free article. Clinical Trial.

8

Raltitrexed ('Tomudex') and radiotherapy can be combined as postoperative treatment for rectal cancer.

Botwood N, James R, Vernon C, Price P. Botwood N, et al. Ann Oncol. 2000 Aug;11(8):1023-8. doi: 10.1023/a:1008376306429. Ann Oncol. 2000. PMID: 11038040 Free article. Clinical Trial.

9

Economic evaluation of gemcitabine alone and in combination with cisplatin in the treatment of nonsmall cell lung cancer.

Lees M, Aristides M, Maniadakis N, McKendrick J, Botwood N, Stephenson D. Lees M, et al. Among authors: botwood n. Pharmacoeconomics. 2002;20(5):325-37. doi: 10.2165/00019053-200220050-00004. Pharmacoeconomics. 2002. PMID: 11994042 Clinical Trial.

10

Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK.

Aristides M, Lees M, Botwood N, McKendrick J, Stephenson DA, Maniadakis N. Aristides M, et al. Among authors: botwood n. Eur J Health Econ. 2003 Sep;4(3):216-21. doi: 10.1007/s10198-003-0173-6. Epub 2003 Jul 1. Eur J Health Econ. 2003. PMID: 15609188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page